ArticleCardio-oncology (London, England)2025

The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Naoki Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.